Spain · Delayed Price · Currency is EUR Tubacex Statistics
Total Valuation
Tubacex has a market cap or net worth of EUR 371.69 million. The enterprise value is 866.14 million.
| Market Cap | 371.69M |
| Enterprise Value | 866.14M |
Important Dates
The last earnings date was Friday, July 24, 2026.
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | Jun 12, 2026 |
Share Statistics
Tubacex has 122.27 million shares outstanding. The number of shares has decreased by -20.35% in one year.
| Current Share Class | 122.27M |
| Shares Outstanding | 122.27M |
| Shares Change (YoY) | -20.35% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 33.45% |
| Float | 97.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.84 |
| PS Ratio | 0.54 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | 17.63 |
| P/OCF Ratio | 5.77 |
| PEG Ratio | 0.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.71, with an EV/FCF ratio of 41.07.
| EV / Earnings | n/a |
| EV / Sales | 1.26 |
| EV / EBITDA | 22.71 |
| EV / EBIT | n/a |
| EV / FCF | 41.07 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.23 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 13.40 |
| Debt / FCF | 24.16 |
| Interest Coverage | -0.39 |
Financial Efficiency
Return on equity (ROE) is -9.82% and return on invested capital (ROIC) is -1.43%.
| Return on Equity (ROE) | -9.82% |
| Return on Assets (ROA) | -0.54% |
| Return on Invested Capital (ROIC) | -1.43% |
| Return on Capital Employed (ROCE) | -1.65% |
| Weighted Average Cost of Capital (WACC) | 5.48% |
| Revenue Per Employee | 248,552 |
| Profits Per Employee | -16,763 |
| Employee Count | 2,619 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 0.73 |
Taxes
| Income Tax | -1.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.97% in the last 52 weeks. The beta is 0.51, so Tubacex's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -14.97% |
| 50-Day Moving Average | 3.21 |
| 200-Day Moving Average | 3.23 |
| Relative Strength Index (RSI) | 40.24 |
| Average Volume (20 Days) | 252,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Tubacex had revenue of EUR 684.76 million and -46.18 million in losses. Loss per share was -0.48.
| Revenue | 684.76M |
| Gross Profit | 372.12M |
| Operating Income | -10.89M |
| Pretax Income | -42.62M |
| Net Income | -46.18M |
| EBITDA | 36.28M |
| EBIT | -10.89M |
| Loss Per Share | -0.48 |
Balance Sheet
The company has 120.87 million in cash and 509.39 million in debt, with a net cash position of -388.52 million or -3.18 per share.
| Cash & Cash Equivalents | 120.87M |
| Total Debt | 509.39M |
| Net Cash | -388.52M |
| Net Cash Per Share | -3.18 |
| Equity (Book Value) | 397.48M |
| Book Value Per Share | 2.38 |
| Working Capital | 121.06M |
Cash Flow
In the last 12 months, operating cash flow was 64.42 million and capital expenditures -43.33 million, giving a free cash flow of 21.09 million.
| Operating Cash Flow | 64.42M |
| Capital Expenditures | -43.33M |
| Depreciation & Amortization | 47.17M |
| Net Borrowing | -18.15M |
| Free Cash Flow | 21.09M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 54.34%, with operating and profit margins of -1.59% and -6.74%.
| Gross Margin | 54.34% |
| Operating Margin | -1.59% |
| Pretax Margin | -6.22% |
| Profit Margin | -6.74% |
| EBITDA Margin | 5.30% |
| EBIT Margin | -1.59% |
| FCF Margin | 3.08% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 6.70%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 6.70% |
| Dividend Growth (YoY) | -75.44% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 20.35% |
| Shareholder Yield | 27.04% |
| Earnings Yield | -12.43% |
| FCF Yield | 5.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Tubacex is 4.14, which is 36.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 4.14 |
| Price Target Difference | 36.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 7.73% |
| EPS Growth Forecast (3Y) | 39.94% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Tubacex has an Altman Z-Score of 0.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.98 |
| Piotroski F-Score | 3 |